Hera System for Infertility
(LOTUS Trial)
Trial Summary
What is the purpose of this trial?
This trial aims to see if using the Hera System can improve pregnancy rates in patients undergoing fertility treatments. The system helps embryologists choose the best embryos by providing extra information, potentially increasing the chances of pregnancy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Eligibility Criteria
This trial is for women aged 21-43 undergoing in vitro fertilization with their own eggs, who have retrieved at least 8 eggs and are planning a single embryo transfer. They must be willing to follow the study's rules and speak English. Those using donor sperm are eligible, but not those using surgically removed sperm or donor eggs, intending to bank embryos, having cancer history, or aiming for gender selection.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Embryos are evaluated using the Hera System alongside traditional morphology grading to determine suitability for transfer
Follow-up
Participants are monitored for clinical pregnancy, defined as a fetal heartbeat at 6-8 weeks
Treatment Details
Interventions
- Hera Score
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alife Health
Lead Sponsor